The Human Research Ethics Committee (HREC) in Australia has granted clearance for Cullinan Therapeutics to commence an ...

Phase 1 clinical trial is designed to assess the safety, pharmacokinetics and initial clinical activity of CLN-978 for ...

BTIG analyst Julian Harrison maintained a Buy rating on Cullinan Management (CGEM – Research Report) yesterday and set a price target of ...

Wedbush analyst Robert Driscoll initiated coverage with a Buy rating on Cullinan Management (CGEM – Research Report) today and set a ...

Nicholas Cullinan, the new director of the British Museum, has announced a groundbreaking $1.3 billion transformation plan, ...

Shane Warne was the undeniable spin king, but his razor-sharp tongue proved to an equally venomous weapon. Warne took more ...

The exhibit is open to the public on Fridays to Sundays, from September 13 to October 6. Entrance is free, but donations are ...

On Tuesday, the Peoria City Council is scheduled to review a proposal from city staff to purchase the 11-story PNC Building, ...

Stifel has recently initiated Cullinan Therapeutics Inc (CGEM) stock to Buy rating, as announced on May 1, 2024, according to Finviz. Earlier, on April 15, 2024, William Blair had initiated the stock ...

Catholics in Waterford gathered in their hundreds this week to venerate the relics of St Bernadette of Lourdes in the ...

Ayanda Thabethe caused a buzz after posting a picture of her R10 million Rolls Royce Cullinan on social media. Fans blamed ...

CAMBRIDGE, Mass. - Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a biopharmaceutical company, announced today that it has received approval from Australia's Human Research Ethics Committee (HREC ...